Cosmos Health targets 2029 revenue USD 200.6 million, net income USD 31 million
COSM•Cosmos Health issued 2029 guidance targeting revenue of USD 200.6 million and net income of USD 31 million.
1. 2029 outlook
The company also targets gross profit of USD 71.2 million and adjusted EBITDA of USD 44.2 million in 2029. CosmoFarm reported Q2 2026 revenue above USD 15 million, implying an annualized run-rate above USD 60 million; automation expansion is expected to add more than USD 40 million in annual revenue capacity, positioning it above USD 100 million annualized.




